Gunderson Dettmer has advised Modular AI. Modular AI has entered into an agreement to be acquired by Qualcomm, with Gunderson Dettmer providing legal counsel to Modular...
Qualcomm to Acquire Modular AI
Hims & Hers Announces Acquisition of YourBio Health
Gunderson Dettmer has advised Hims & Hers. Hims & Hers Health, Inc. (NYSE: HIMS) has entered into a definitive agreement to acquire YourBio Health, Inc., a...
CrowdStrike Acquires Pangea to Enhance AI Security Platform
Gunderson Dettmer has advised Pangea. Pangea, a leader in AI security, has entered into a definitive agreement to be acquired by CrowdStrike. The acquisition is set...
Varonis Systems’ Acquisition of Cyral
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Cyral in the transaction. Varonis Systems (Nasdaq: VRNS) (Varonis), a leader in data security, announced its acquisition of...
CoverForce’s $13 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented CoverForce in the transaction. CoverForce, a leading infrastructure platform for commercial insurance, announced raising $13 million in Series...
Karat’s Acquisition of Byteboard
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Karat in the transaction. Karat, a partner for measuring and elevating technical talent, announced its acquisition of Byteboard,...
Twelve’s $645 Million Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Twelve in the deal. Twelve, a carbon transformation company, announced raising $645 million financing. The new capital will...
Incode’s Acquisition of MetaMap
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Incode Technologies Inc. in the transaction. Incode Technologies Inc. (Incode), a global leader in trust and identity, announced...
Radar Therapeutics’ $13.4 Million Seed Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Radar Therapeutics on the deal, and Wilson Sonsini Goodrich & Rosati advised Radar Therapeutics on IP matters related...
Alamar Biosciences’ $128 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing...
AstraZeneca’s Acquisition of TeneoTwo
Gunderson Dettmer advised TeneoTwo on the deal. TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery,...
Ancora Biotech’s $60 Million Series A Financing
Gunderson Dettmer represented Ancora Biotech on the deal. Ancora Biotech, a California-based biotechnology company, announced its $60 million Series A financing co-led by Lightspeed Venture Partners and...